A detailed history of Capstone Triton Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capstone Triton Financial Group, LLC holds 20,099 shares of ABT stock, worth $2.09 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
20,099
Previous 20,893 3.8%
Holding current value
$2.09 Million
Previous $2.3 Million 0.65%
% of portfolio
1.64%
Previous 1.69%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $86,958 - $96,042
-794 Reduced 3.8%
20,099 $2.28 Million
Q4 2023

Jan 09, 2024

SELL
$90.19 - $110.4 $316,747 - $387,724
-3,512 Reduced 14.39%
20,893 $2.3 Million
Q3 2023

Oct 11, 2023

BUY
$95.53 - $114.62 $33,817 - $40,575
354 Added 1.47%
24,405 $2.36 Million
Q2 2023

Jul 17, 2023

BUY
$100.78 - $112.29 $9,271 - $10,330
92 Added 0.38%
24,051 $2.62 Million
Q1 2023

Apr 06, 2023

BUY
$96.86 - $114.01 $10,364 - $12,199
107 Added 0.45%
23,959 $2.43 Million
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $33,271 - $39,032
350 Added 1.49%
23,852 $0
Q3 2022

Oct 28, 2022

SELL
$96.76 - $112.03 $7,450 - $8,626
-77 Reduced 0.33%
23,502 $2.27 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $13,167 - $15,914
-129 Reduced 0.54%
23,579 $2.61 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $2.7 Million - $3.3 Million
23,708 New
23,708 $2.77 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $3.01 Million - $3.69 Million
-26,076 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $52,613 - $58,206
-451 Reduced 1.7%
26,076 $3.3 Million
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $846 - $996
8 Added 0.03%
26,527 $3.08 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $29,931 - $35,263
-275 Reduced 1.03%
26,519 $3.18 Million
Q4 2020

Jan 28, 2021

BUY
$105.0 - $114.42 $2.81 Million - $3.07 Million
26,794 New
26,794 $2.93 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capstone Triton Financial Group, LLC Portfolio

Follow Capstone Triton Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Triton Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Triton Financial Group, LLC with notifications on news.